These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29446221)

  • 21. Engineering aldolases for asymmetric synthesis.
    Widersten M
    Methods Enzymol; 2020; 644():149-167. PubMed ID: 32943143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient laboratory evolution of computationally designed enzymes with low starting activities using fluorescence-activated droplet sorting.
    Obexer R; Pott M; Zeymer C; Griffiths AD; Hilvert D
    Protein Eng Des Sel; 2016 Sep; 29(9):355-66. PubMed ID: 27542390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of small designer aldolase enzymes: catalytic activity, folding, and substrate specificity.
    Tanaka F; Fuller R; Barbas CF
    Biochemistry; 2005 May; 44(20):7583-92. PubMed ID: 15896002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Redesigning Aldolase Stereoselectivity by Homologous Grafting.
    Bisterfeld C; Classen T; Küberl I; Henßen B; Metz A; Gohlke H; Pietruszka J
    PLoS One; 2016; 11(6):e0156525. PubMed ID: 27327271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereodivergent atom-transfer radical cyclization by engineered cytochromes P450.
    Zhou Q; Chin M; Fu Y; Liu P; Yang Y
    Science; 2021 Dec; 374(6575):1612-1616. PubMed ID: 34941416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in biocatalysis by directed enzyme evolution.
    Rubin-Pitel SB; Zhao H
    Comb Chem High Throughput Screen; 2006 May; 9(4):247-57. PubMed ID: 16724916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Boron catalysis in a designer enzyme.
    Longwitz L; Leveson-Gower RB; Rozeboom HJ; Thunnissen AWH; Roelfes G
    Nature; 2024 May; 629(8013):824-829. PubMed ID: 38720081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asymmetric Alkylation of Ketones Catalyzed by Engineered TrpB.
    Watkins-Dulaney EJ; Dunham NP; Straathof S; Turi S; Arnold FH; Buller AR
    Angew Chem Int Ed Engl; 2021 Sep; 60(39):21412-21417. PubMed ID: 34269506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory evolution of stereoselective enzymes: a prolific source of catalysts for asymmetric reactions.
    Reetz MT
    Angew Chem Int Ed Engl; 2011 Jan; 50(1):138-74. PubMed ID: 20715024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of Enzyme Mechanism along the Evolutionary Trajectory of a Computationally Designed (Retro-)Aldolase.
    Zeymer C; Zschoche R; Hilvert D
    J Am Chem Soc; 2017 Sep; 139(36):12541-12549. PubMed ID: 28783336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A QM/MM study on the origin of retro-aldolase activity of a catalytic antibody.
    De Raffele D; Martí S; Moliner V
    Chem Commun (Camb); 2021 May; 57(43):5306-5309. PubMed ID: 33912877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A thermostable variant of fructose bisphosphate aldolase constructed by directed evolution also shows increased stability in organic solvents.
    Hao J; Berry A
    Protein Eng Des Sel; 2004 Sep; 17(9):689-97. PubMed ID: 15531627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rationally designed aldolase foldamer.
    Müller MM; Windsor MA; Pomerantz WC; Gellman SH; Hilvert D
    Angew Chem Int Ed Engl; 2009; 48(5):922-5. PubMed ID: 19090515
    [No Abstract]   [Full Text] [Related]  

  • 34. Directed evolution and the creation of enantioselective biocatalysts.
    Jaeger KE; Eggert T; Eipper A; Reetz MT
    Appl Microbiol Biotechnol; 2001 May; 55(5):519-30. PubMed ID: 11414315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzymes useful for chiral compound synthesis: structural biology, directed evolution, and protein engineering for industrial use.
    Kataoka M; Miyakawa T; Shimizu S; Tanokura M
    Appl Microbiol Biotechnol; 2016 Jul; 100(13):5747-57. PubMed ID: 27188776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methodology Development in Directed Evolution: Exploring Options when Applying Triple-Code Saturation Mutagenesis.
    Qu G; Lonsdale R; Yao P; Li G; Liu B; Reetz MT; Sun Z
    Chembiochem; 2018 Feb; 19(3):239-246. PubMed ID: 29314451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational design of stereoselectivity in the class II pyruvate aldolase BphI.
    Baker P; Seah SY
    J Am Chem Soc; 2012 Jan; 134(1):507-13. PubMed ID: 22081904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substrate-driven chemotactic assembly in an enzyme cascade.
    Zhao X; Palacci H; Yadav V; Spiering MM; Gilson MK; Butler PJ; Hess H; Benkovic SJ; Sen A
    Nat Chem; 2018 Mar; 10(3):311-317. PubMed ID: 29461522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Varying the Directionality of Protein Catalysts for Aldol and Retro-Aldol Reactions.
    Fujioka T; Numoto N; Akama H; Shilpa K; Oka M; Roy PK; Krishna Y; Ito N; Baker D; Oda M; Tanaka F
    Chembiochem; 2022 Jan; 23(2):e202100435. PubMed ID: 34698422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inclusion bodies of fuculose-1-phosphate aldolase as stable and reusable biocatalysts.
    Sans C; García-Fruitós E; Ferraz RM; González-Montalbán N; Rinas U; López-Santín J; Villaverde A; Álvaro G
    Biotechnol Prog; 2012; 28(2):421-7. PubMed ID: 22275283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.